POSA148 Cost Effectiveness of Ofatumumab in Comparison with Other Disease Modifying Therapies and Best Supportive Care for the Treatment of Relapsing-Remitting Multiple Sclerosis in Canada
| Autor: | Mouallif, S, Thomas, K, Adlard, NE, Cooney, P, Blanchette, F, Patel, BP, Baharnoori, M, Bhan, V, Clift, F, Grima, D |
|---|---|
| Zdroj: | In Value in Health January 2022 25(1) Supplement:S63-S63 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect